GlassScriptPhysician profile
Emily Delfino
NPI 1457075509
$226.81
in general payments reported to CMS, 2019-2025
9 companies · $60.25 in 2025
The $60.25 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $94.95 · 2024: $71.61 · 2025: $60.25.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $227.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $226.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $54.15 | 2024 | Azstarys |
| Ironshore Pharmaceuticals INC. | $37.18 | 2023-2024 | Jornay Pm |
| Alk-Abello, INC | $27.03 | 2025 | Neffy |
| Pfizer INC. | $21.52 | 2023 | |
| Sanofi Pasteur INC. | $18.54 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $18.14 | 2023 | Flumist Quadrivalent |
| Lnhc, INC | $17.42 | 2025 | Zelsuvmi |
| Merck Sharp & Dohme LLC | $17.03 | 2023 | Gardasil 9, Vaxelis, Vaxneuvance |
| Collegium Pharmaceutical, INC. | $15.80 | 2025 | Jornay Pm |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emily Delfino listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.